期刊文献+

血浆NT-proBNP、血清ST2与急性失代偿性心力衰竭预后评估 被引量:21

The Plasma NT-proBNP and Serum ST2 of Acute Decompensated Heart Failure Patients for Evaluation of Prognosis
下载PDF
导出
摘要 目的 观察急性失代偿性心力衰竭(ADHF)患者血浆NT-proBNP和血清ST2水平变化,探讨其与ADHF患者预后的关系.方法 选取2011年7月~2012年4月期间急诊科就诊的ADHF患者75例(心衰组),根据预后分为事件组30例及非事件组45例;选取同期健康体检者42例为对照组.检测并比较血浆NT-proBNP、血清ST2、CK-MB、cTnI及超声心动图等指标.结果 ADHF患者NT-proBNP、ST2均高于对照组(P<0.01);事件组NT-proBNP、ST2和cTnI均高于非事件组(P<0.01或P<0.05);NT-proBNP、ST2和cTnI与预后呈正相关.Logistic回归分析显示,NT-proBNP [B=1.61,P<0.01,OR=4.43,95%CI=(2.20~10.98)]和ST2[B=1.7,P<0.01,OR=2.03,95%CI(1.47~4.16)]是不良预后的独立预测因子.结论 NT-proBNP、ST2水平升高是ADHF患者不良预后的危险因素. Objective To study plasma NT-proBNP and serum ST2 of acute decompensated heart failure patients (ADHF) for evaluation of the prognosis. Methods Seventy-five patients with ADHF (HF group) were selected from July 2011 to April 2012 in the emergency department. Patients were divided according to the prognosis into the events of 30 cases, the non-events of 45 patients, and 42 normal healthy people were used as controls. Their plasma levels of NT-proBNP and serum levels of ST2 ,as well as plasma levels of CK-MB,cTnI were measured and echocardiography were perforomed and compared, Results The NT-proBNP and ST2,of ADHF group were higher than the control group (P〈0.01). In events group. NT-proBNP, ST2, and cTnI were higher than the non-events group (P〈0.01 or P〈0.05). NT-proBNP, ST2 and cTnI were positively correlated with the outcome. Logistic regression showed that NT-proBNP was B= 1.61, P〈0.01,OR=4.43,95 %CI= 2.20-10.98 and ST2 was B=1.7, P〈0. 01, OR = 2.03,95% CI= 1.47-4. 16. Conclusion High level of NT-proBNP and ST2 are risk factors for adverse outcomes in patients with ADHF.
作者 贺明轶 秦俭
出处 《成都医学院学报》 CAS 2014年第2期142-145,共4页 Journal of Chengdu Medical College
关键词 急性失代偿性心力衰竭 NT-PROBNP ST2 预后 Acute Decompensated Heart Failure N-Terminal Probrain Natriuretic Peptides ST2 Prognosis
  • 相关文献

参考文献20

  • 1Tominaga S. A putative protein of a growth specific cDNA from BALB/e-3T3 cells is highly similar to the extracellular portion of mouse interleukin 1 receptor[J]. FEBS Letters, 1989, 258(2): 301-304. 被引量:1
  • 2Sanada S, Hakuno D, Higgins LJ, et al. IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system [J]. Journal of Clinical Investigation, 2007, 117(6): 1538-1549. 被引量:1
  • 3Gruson D, Lepoutre T, Ahn SA, et al. Increased soluble ST2 is a stronger predictor of long-term cardiovascular death than natriuretic peptides in heart failure patients with reduced ejection fraction [J]. International Journal of Cardiology, 2014,172 (1) : 250-252. 被引量:1
  • 4Lupon J, de Antonio M, Vila J, et al. Development of a Novel Heart Failure Risk Tooh The Barcelona Bio-Heart Failure Risk Calculator (BCN Bio-HF Calculator)[J]. PloS One, 2014, 9(1): 85466. 被引量:1
  • 5Lassus J, Gayat E, Mueller C, et al. Incremental value of hiomarkers to clinical variables for mortality prediction in acutely decompensated heart failure: the Multinational Observational Cohort on Acute Heart Failure (MOCA) study [J]. International Journal of Cardiology, 2013, 168 (3): 2186-2194. 被引量:1
  • 6Noveanu M, Breidthardt T, Potocki M, et al. Direct comparison of serial B-type natriuretic peptide and NT- proBNP levels for prediction of short-and long-term outcome in acute decompensated heart failure[J]. Crit Care, 2011, 15 (1): 1. 被引量:1
  • 7Pfister R, Schneider CA. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: application of natriuretic peptides [J ]. European Heart Journal, 2009, 30(3): 382-383. 被引量:1
  • 8急性心力衰竭诊断和治疗指南[J].中华心血管病杂志,2010,38(3):195-208. 被引量:835
  • 9Januzzi JL, Peacock WF, Maisel AS, et al. Measurement of the Interleukin Family Member ST2 in Patients With Acute DyspneaResults From the PRIDE (Pro-Brain NatriureticPeptide Investigation of Dyspnea in the Emergency Department) Study[J]. Journal of the American College of Cardiology, 2007, 50(7): 607-613. 被引量:1
  • 10Shimpo M, Morrow DA, Weinberg EO, et al. Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction [J]. Circulation, 2004, 109(18): 2186-2190. 被引量:1

二级参考文献39

  • 1谢洪智,朱文玲.重组人脑利钠肽和硝酸甘油治疗急性失代偿性心力衰竭疗效和安全性的随机、开放、平行对照的多中心临床研究[J].中华心血管病杂志,2006,34(3):222-226. 被引量:228
  • 2中华医学会心血管病学分会 中华心血管病杂志编辑委员会.β肾上腺素能受体阻滞剂在心血管疾病应用的专家共识[J].中华心血管病杂志,2009,37:195-209. 被引量:4
  • 3中华医学会心血管病学分会 中华心血管病杂志编辑委员会.慢性心力衰竭诊断治疗建议.中华心血管病杂志,2007,35(12):1076-1095. 被引量:31
  • 4Nieminen MS, Bohm M, Cowie MR, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J, 2005, 26: 384-416. 被引量:1
  • 5Task Force for Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of European Society of Cardiology. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 : the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC ( HFA ) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J, 2008, 29 : 2388-2442. 被引量:1
  • 6Hunt SA, American College of Cardiology, American Heart Association Task Force on Practice Guidelines ( Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure ). ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart fa/lure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines ( Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol, 2005, 46: e1-e82. 被引量:1
  • 7Jessup M, Abraham WT, Casey DE, et al. 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Aduks: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines : developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation, 2009, 119: 1977-2016. 被引量:1
  • 8Liang KV, Williams AW, Greene EL, et al. Acute decompensated heart failure and the cardiorenal syndrome. Crit Care Med, 2008, 36(1 Suppl) : S75-S88. 被引量:1
  • 9Chen D, Assad-Kottner C, Orrego C, et al. Cytokines and acute heart failure. Crit Care Med, 2008, 36(1 Suppl) : S9-S16. 被引量:1
  • 10Chen AA, Wood MJ, Krauser DG, et al. NT-proBNP levels, echocardiographic findings, and outcomes in breathless patients: results from the ProBNP Investigation of Dyspnoea in the Emergency Department (PRIDE) echocardiographic substudy. Eur Heart J, 2006, 27 : 839-845. 被引量:1

共引文献834

同被引文献195

引证文献21

二级引证文献161

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部